Ben Hendrix

RBC Capital | Healthcare

Ben Hendrix is an analyst from RBC Capital specializing in the Healthcare sector. Ranked #1189 out of 4542 analysts, they have issued 57 stock ratings with a success rate of 92.67% and an average return of 17.08%.

Ben Hendrix has a well-established track record, with 57 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 92.67% and an average return of 17.08%, underscoring their expertise and ability to identify winning opportunities for investors.

#1189

Out of 4542

57

Total Ratings

+92.67%

Success Rate

+17.08%

Average Return

Recent Ratings Analysis

HUM

Feb 12, 2026

Target

$322.00

Current

$178.83

Performance

0.00%

Ben Hendrix rated HUM as Sector Perform on Feb 12, 2026, setting a price target of 322. The Hold stance appears justified, as shares hovered around 178.83 with a 0.00% move.

THC

Feb 12, 2026

Target

$277.00

Current

$232.26

Performance

0.00%

On Feb 12, 2026, THC was given a Outperform rating by Ben Hendrix, with a target price of 277. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.

SLQT

Feb 11, 2026

Target

$5.00

Current

$0.84

Performance

-4.24%

SLQT received a Sector Perform rating from Ben Hendrix on Feb 11, 2026, aiming for 5. Shares remained flat at 0.8427, aligning with the neutral rating.

ENSG

Feb 09, 2026

Target

$222.00

Current

$214.41

Performance

7.59%

On Feb 09, 2026, Ben Hendrix published a Outperform outlook on ENSG, with a target of 222. Shares gained 7.59%, underscoring the accuracy of the bullish outlook toward 222.

CI

Feb 06, 2026

Target

$333.00

Current

$287.61

Performance

-1.52%

Ben Hendrix on Feb 06, 2026 assigned CI a Outperform rating, with a price target of 333. The recommendation remains pending validation as shares consolidate around 287.61.

CON

Feb 02, 2026

Target

$31.00

Current

$23.89

Performance

7.86%

On Feb 02, 2026, Ben Hendrix reaffirmed CON with a Outperform rating, targeting 31. The recommendation was supported by strong follow-through as the stock rose from 23.89 to 23.89.

BKD

Jan 29, 2026

Target

$17.00

Current

$16.31

Performance

12.48%

BKD was rated Outperform by Ben Hendrix on Jan 29, 2026, with a price objective of 17. A bullish response from the market helped close the gap of 0.69 to the target.

HCA

Jan 28, 2026

Target

$555.00

Current

$535.22

Performance

8.96%

On Jan 28, 2026, Ben Hendrix initiated coverage on HCA with a Outperform rating and target of 555. The stock’s climb of 8.96% since the call highlights the foresight in the rating.

UNH

Jan 28, 2026

Target

$361.00

Current

$284.37

Performance

-3.28%

Ben Hendrix issued a Outperform recommendation for UNH on Jan 28, 2026, price target set at 361. The target of 361 remains in play, though confirmation will depend on future moves.

AVAH

Jan 15, 2026

Target

$11.00

Current

$7.83

Performance

-19.77%

On Jan 15, 2026, AVAH was evaluated by Ben Hendrix, who gave a Sector Perform rating and target of 11. The Hold call avoided chasing into subsequent weakness of 19.77%.

ACHC

Jan 14, 2026

Target

$17.00

Current

$15.89

Performance

35.46%

Ben Hendrix rated ACHC as Outperform on Jan 14, 2026, setting a price target of 17. The call has proven timely, with shares rising 35.46% toward the price target of 17.

GOCO

Nov 26, 2025

Target

$12.00

Current

$1.75

Performance

-40.10%

On Nov 26, 2025, GOCO was given a Sector Perform rating by Ben Hendrix, with a target price of 12. The rating provided protection from downside risk as the stock fell to 1.755.

EHTH

Nov 25, 2025

Target

$10.00

Current

$1.64

Performance

-58.59%

EHTH received a Sector Perform rating from Ben Hendrix on Nov 25, 2025, aiming for 10. The Hold stance proved prudent, with the market softening by 58.59%.

PACS

Nov 20, 2025

Target

$33.00

Current

$38.91

Performance

48.85%

On Nov 20, 2025, Ben Hendrix published a Outperform outlook on PACS, with a target of 33. Shares gained 48.85%, underscoring the accuracy of the bullish outlook toward 33.

PNTG

Nov 17, 2025

Target

$39.00

Current

$31.16

Performance

22.68%

Ben Hendrix on Nov 17, 2025 assigned PNTG a Outperform rating, with a price target of 39. The Buy call aligned well with market performance, producing a gain of 22.68%.

ARDT

Nov 14, 2025

Target

$16.00

Current

$9.48

Performance

5.22%

On Nov 14, 2025, Ben Hendrix reaffirmed ARDT with a Outperform rating, targeting 16. The recommendation was supported by strong follow-through as the stock rose from 9.48 to 9.48.

SGRY

Nov 11, 2025

Target

$31.00

Current

$15.49

Performance

-1.59%

SGRY was rated Outperform by Ben Hendrix on Nov 11, 2025, with a price objective of 31. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

CHE

Nov 10, 2025

Target

$572.00

Current

$463.95

Performance

6.41%

On Nov 10, 2025, Ben Hendrix initiated coverage on CHE with a Outperform rating and target of 572. The stock’s climb of 6.41% since the call highlights the foresight in the rating.

ADUS

Nov 07, 2025

Target

$139.00

Current

$112.30

Performance

-0.69%

Ben Hendrix issued a Outperform recommendation for ADUS on Nov 07, 2025, price target set at 139. The target of 139 remains in play, though confirmation will depend on future moves.

UHS

Sector Performer

Oct 30, 2025

Target

$231.00

Current

$234.05

Performance

7.02%

On Oct 30, 2025, UHS was evaluated by Ben Hendrix, who gave a Sector Performer rating and target of 231.

CVS

Oct 30, 2025

Target

$93.00

Current

$77.93

Performance

1.62%

Ben Hendrix rated CVS as Outperform on Oct 30, 2025, setting a price target of 93. Shares have remained stable near 77.93, leaving the 93 target still in play.

SEM

Oct 08, 2025

Target

$20.00

Current

$16.29

Performance

14.40%

On Oct 08, 2025, SEM was given a Outperform rating by Ben Hendrix, with a target price of 20. The stock rallied 14.40% after the rating, narrowing the gap to the target of 20 and validating the bullish stance.

CYH

Jul 25, 2025

Target

$5.00

Current

$3.44

Performance

24.19%

CYH received a Outperform rating from Ben Hendrix on Jul 25, 2025, aiming for 5. Momentum has favored the Buy call, with shares climbing from 3.44 to 3.44, rewarding those who trusted the recommendation.

AHCO

Feb 26, 2025

Target

$14.00

Current

$10.09

Performance

-9.10%

On Feb 26, 2025, Ben Hendrix published a Outperform outlook on AHCO, with a target of 14. Market action contradicted the Buy thesis, as shares slipped to 10.09.

MAX

Feb 25, 2025

Target

$20.00

Current

$7.47

Performance

-19.68%

Ben Hendrix on Feb 25, 2025 assigned MAX a Outperform rating, with a price target of 20. The call has struggled to gain traction, with shares losing 19.68%.

EHC

Feb 11, 2025

Target

$110.00

Current

$112.06

Performance

12.74%

On Feb 11, 2025, Ben Hendrix reaffirmed EHC with a Outperform rating, targeting 110. The recommendation was supported by strong follow-through as the stock rose from 112.06 to 112.06.

WBA

Jan 15, 2025

Target

$12.00

Current

$11.98

Performance

-4.39%

WBA was rated Sector Perform by Ben Hendrix on Jan 15, 2025, with a price objective of 12. Flat performance suggests the Hold view was reasonable.

NEUE

Dec 09, 2024

Target

$7.00

Current

$6.75

Performance

26.22%

On Dec 09, 2024, Ben Hendrix initiated coverage on NEUE with a Sector Perform rating and target of 7. The Hold stance underestimated the stock’s strength as it gained 26.22%.

ELV

Jul 18, 2024

Target

$585.00

Current

$336.04

Performance

-33.42%

Ben Hendrix issued a Outperform recommendation for ELV on Jul 18, 2024, price target set at 585. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Frequency Asked Questions

Who is Ben Hendrix?

Ben Hendrix is an analyst from RBC Capital specializing in the Healthcare sector.

What is Ben Hendrix's success rate?

Ben Hendrix currently has a success rate of +92.67%.

How many ratings has Ben Hendrix issued?

Ben Hendrix has issued 57 stock ratings so far.

What is the average return of Ben Hendrix's calls?

Their stock ratings have generated an average return of +17.08%.

What is Ben Hendrix's ranking?

Ben Hendrix is ranked #1189 out of 4542 analysts.

What types of ratings does Ben Hendrix give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Ben Hendrix?

You can follow Ben Hendrix by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Ben Hendrix?

Their latest rating was a Hold on HUM issued on 2026-02-12.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep